Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The provider must interpret the finding and name the diagnosis in the assessment
Manufacturing standards should also factor into supplier evaluation
AOD-9604 is a synthetic peptide derived from a specific fragment of human growth hormone (HGH), originally developed as a potential treatment for obesity
Typical injectable GHK-Cu dose ranges Standard starting dose: 1 mg per day subcutaneous Conservative / beginner dose: 0.5 mg per day Intensive / wound-healing dose: 23 mg per day Upper research range: 4 mg per day (rarely exceeded) Frequency: once daily, or split into morning + evening microdoses for steadier levels Route: subcutaneous (SC) injection - typically abdomen , thigh or flank
US$ 25.91
US$ 22.31
US$ 21.02
US$ 20.52
US$ 26.97
